HighVia—A Flexible Live-Cell High-Content Screening Pipeline to Assess Cellular Toxicity

High-content screening to monitor disease-modifying phenotypes upon small-molecule addition has become an essential component of many drug and target discovery platforms. One of the most common phenotypic approaches, especially in the field of oncology research, is the assessment of cell viability....

Descripción completa

Detalles Bibliográficos
Autores principales: Howarth, Alison, Schröder, Martin, Montenegro, Raquel C., Drewry, David H., Sailem, Heba, Millar, Val, Müller, Susanne, Ebner, Daniel V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522770/
https://www.ncbi.nlm.nih.gov/pubmed/32458721
http://dx.doi.org/10.1177/2472555220923979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522770/
https://www.ncbi.nlm.nih.gov/pubmed/32458721
http://dx.doi.org/10.1177/2472555220923979

Ejemplares similares